Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Rang în acțiuni #28164
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Preț acțiune
$0.5495
Ultima sincronizare: 2025-05-15
Capitalizare de piață
$28.14M
Schimbare (1 zi)
4.70%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Enzo Biochem, Inc. (ENZ)

Categorie

Prețul ENZ cu capitalizarea de piață a B
Enzo Biochem, Inc. Enzo Biochem, Inc.
ENZ
$0.5495
Capitalizarea de piață a Enzo Biochem, Inc.(ENZ)
Capitalizare de piață: $28.14M
În anul August 2026, Enzo Biochem, Inc. are o capitalizare de piață de $28.14M. Acest lucru face ca Enzo Biochem, Inc. să fie a 28164th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Enzo Biochem, Inc. din 1980 până în 2026
ENZ în comparație cu top 5 cele mai populare stocks
Prețul pentru ENZ Activul B Capitalizarea de piață a B Rezultate
Enzo Biochem, Inc. Enzo Biochem, Inc.
$103,498 $28.14M
$5.301T +18,834,759.37%
Enzo Biochem, Inc. Enzo Biochem, Inc.
$90,474.62 $28.14M
$4.634T +16,464,798.58%
Enzo Biochem, Inc. Enzo Biochem, Inc.
$80,890.22 $28.14M
$4.143T +14,720,594.94%
Enzo Biochem, Inc. Enzo Biochem, Inc.
$70,081.22 $28.14M
$3.589T +12,753,534.18%
Enzo Biochem, Inc. Enzo Biochem, Inc.
$55,780.90 $28.14M
$2.857T +10,151,110.31%